logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Critical Care Diagnostics, Inc.

Calculating rank
USPTO Granted Patents = 35

% Expired Patents = 40.0



Trademarks = 3

Forward Citations = 376

Loading Chart...
Loading Chart...

10 inventors (with patents filed for the assignee):

goldMedal James V Snider (35 out of 35 patents)

silverMedal Sven Jacobson (9 out of 42 patents)

bronzeMedal Robert W Gerwien (7 out of 8 patents)

4.  Jillian Elizabeth Bender (5 out of 5 patents)

5.  Shrin P Kuo (5 out of 5 patents)

6.  Roy A Chung (5 out of 8 patents)

7.  Eugene R Heyman (4 out of 4 patents)

8.  David Geliebter (3 out of 3 patents)

9.  Timothy Edward Meyer (2 out of 8 patents)

10.  Craig Michael Stolen (2 out of 33 patents)


Core Competencies:
Cardiac Biomarker
ST2
Ventricular Tachyarrhythmia
Adverse Cardiac Events
Heart Failure
Galectin-3
Risk Stratification
Blood Test Kit
Hypertension
Severe Disease Detection
Multimarker
Exercise Therapy

35 patents:

1. 11525828 - Test apparatus and methods for ST2 cardiac biomarker (2022-12-13),
2. 11340236 - Methods for treating or predicting risk of a ventricular tachyarrhythmia event (2022-05-24),
3. 11340222 - Test apparatus and methods for ST2 cardiac biomarker (2022-05-24),
4. 11170896 - Predicting risk of major adverse cardiac events (2021-11-09),
5. 11016103 - Predicting mortality and detecting severe disease (2021-05-25),
6. 10928393 - Methods of treating cardiovascular diseases and predicting the efficacy of exercise therapy (2021-02-23),
7. 10745484 - Soluble human ST-2 antibodies and assays (2020-08-18),
8. 10741290 - Multimarker risk stratification (2020-08-11),
9. 10408845 - Methods for treating or predicting risk of a ventricular tachyarrhythmia event (2019-09-10),
10. 10393756 - Methods of treating a subject having heart failure that include detecting levels of galectin-3 and soluble ST2 (2019-08-27),
11. 10325682 - Test apparatus and methods for ST2 cardiac biomarker (2019-06-18),
12. 10324089 - Test apparatus and methods for ST2 cardiac biomarker (2019-06-18),
13. 10303844 - Multimarker risk stratification (2019-05-28),
14. 10203339 - Diagnosis of cardiovascular disease (2019-02-12),
15. 10079073 - Test apparatus and methods for ST2 cardiac biomarker (2018-09-18),
Company Overview
Critical Care Diagnostics, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative diagnostic solutions for critical care settings. The organization focuses on enhancing patient outcomes through advanced technologies that enable rapid and accurate disease detection. With a commitment to improving healthcare delivery, Critical Care Diagnostics leverages its expertise in biomarker discovery and assay development to address unmet needs in critical care diagnostics.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

35 Patents

#179 in San Diego, CA

#2,311 in California

#9,757 in US

#19,187 in the World

San Diego, CA (US)
San Diego, CA, United States of America

Critical Care Diagnostics, Inc.

Forward Citations = 376

10 inventors:

goldMedal James V Snider (35 out of 35 patents)

silverMedal Sven Jacobson (9 out of 42 patents)

bronzeMedal Robert W Gerwien (7 out of 8 patents)

4.  Jillian Elizabeth Bender (5 out of 5 patents)

5.  Shrin P Kuo (5 out of 5 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Critical Care Diagnostics, Inc.. Retrieved from https://idiyas.com/company/critical-care-diagnostics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…